Unknown

Dataset Information

0

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor?Positive, Human Epidermal Growth Factor 2 (HER2)?Negative Breast Cancer.


ABSTRACT: PURPOSE:This preliminary study was conducted to evaluate the association between Oncotype DX (ODX) recurrence score and traditional prognostic factors. We also developed a nomogram to predict subgroups with low ODX recurrence scores (less than 25) and to avoid additional chemotherapy treatments for those patients. MATERIALS AND METHODS:Clinicopathological and immunohistochemical variables were retrospectively retrieved and analyzed from a series of 485 T1-3N0-1miM0 hormone receptor-positive, human epidermal growth factor 2?negative breast cancer patients with available ODX test results at Asan Medical Center from 2010 to 2016. One hundred twenty-seven patients (26%) had positive axillary lymph node micrometastases, and 408 (84%) had ODX recurrence scores of ?25. Logistic regression was performed to build a nomogram for predicting a low-risk subgroup of the ODX assay. RESULTS:Multivariate analysis revealed that estrogen receptor (ER) score, progesterone receptor (PR) score, histologic grade, lymphovascular invasion (LVI), and Ki-67 had a statistically significant association with the low-risk subgroup. With these variables, we developed a nomogram to predict the low-risk subgroup with ODX recurrence scores of ?25. The area under the receiver operating characteristic curve was 0.90 (95% confidence interval [CI], 0.85 to 0.96). When applied to the validation group the nomogram was accurate with an area under the curve = 0.88 (95% CI, 0.83 to 0.95). CONCLUSION:The low ODX recurrence score subgroup can be predicted by a nomogram incorporating five traditional prognostic factors: ER, PR, histologic grade, LVI, and Ki-67. Our nomogram, which predicts a low-risk ODX recurrence score, will be a useful tool to help select patients who may or may not need additional ODX testing.

SUBMITTER: Lee SB 

PROVIDER: S-EPMC6639212 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer.

Lee Sae Byul SB   Kim Junetae J   Sohn Guiyun G   Kim Jisun J   Chung Il Yong IY   Kim Hee Jeong HJ   Ko Beom Seok BS   Son Byung Ho BH   Ahn Sei-Hyun SH   Lee Jong Won JW   Jung Kyung Hae KH  

Cancer research and treatment 20181101 3


<h4>Purpose</h4>This preliminary study was conducted to evaluate the association between Oncotype DX (ODX) recurrence score and traditional prognostic factors. We also developed a nomogram to predict subgroups with low ODX recurrence scores (less than 25) and to avoid additional chemotherapy treatments for those patients.<h4>Materials and methods</h4>Clinicopathological and immunohistochemical variables were retrospectively retrieved and analyzed from a series of 485 T1-3N0-1miM0 hormone recepto  ...[more]

Similar Datasets

| S-EPMC5387031 | biostudies-literature
| S-EPMC6998376 | biostudies-literature
| S-EPMC6670782 | biostudies-literature
| S-EPMC6763428 | biostudies-literature
| S-EPMC5847032 | biostudies-literature
| S-EPMC9239530 | biostudies-literature
| S-EPMC4696739 | biostudies-literature
| S-EPMC3647116 | biostudies-literature
| S-EPMC4829400 | biostudies-literature
| S-EPMC5241904 | biostudies-other